Review
Copyright ©2014 Baishideng Publishing Group Inc.
World J Hepatol. Jul 27, 2014; 6(7): 486-495
Published online Jul 27, 2014. doi: 10.4254/wjh.v6.i7.486
Table 1 Hepatic tumors characterisctics
Clinical findingsLaboratory findingsBiopsy findingsTherapyOutcome
Hepatic hemangiomaCutaneous hemangiomasDecreased T3, T4Glut-1 positive/negativeObservation Propranolol EmbolizationFavourable
Focal nodular hyperplasiaBleeding Torsion-Glutamine synthetaseObservation SurgeryFavourable
Mesenchymal hamartomaHepatomegaly-Vimentin, desmin, a-1 antitrypsin, actin, cytokeratinsSurgeryFavourable
HepatoblastomaHepatomegalyElevated AFPSmall cells Embryonal epithelial cellsChemotherapy SurgeryEFS 30%-90%
Billiary tract rhabdomyosarcomaJaundice Hilum of the liverCholestasisEmbryonal or botryoid subtypeChemotherapy Radiation therapy SurgeryEFS 60%-90%
AngiosarcomaMetastatic disease-Glut-1 negativeChemotherapy Radiation therapy SurgeryUnfavourable
Malignant rhabdoid tumorMetastatic disease-INI1/BAF 47Chemotherapy SurgeryUnfavourable
Undifferentiated embryonal sarcomaRight lobe of the liver-SMA, a-ACT, desmin, vimentinChemotherapy SurgeryUnfavourable
Metastatic hepatic disease from NBHepatomegalyElevated catecholaminesMYC-NChemotherapy Radiation therapy SurgeryEFS 50%-90%